Cancer Research UK Cambridge Centre’s Post

Black scientists in Cambridge are driving change to help create a cancer research sector that better represents the wider population. Among them, an organisation co-founded by a Cambridge student to champion Black excellence in cancer research is also working to empower the Black community around the disease and break down harmful stigma and misconceptions. Black in Cancer was launched by Sigourney Bonner – with US colleague Dr Henry Henderson – while she was studying for a PhD in paediatric brain tumours at the Cancer Research UK (CRUK) Cambridge Institute, and Cambridge University. Sigourney, who is now a Postdoctoral Associate based at the CRUK Cambridge Institute, said: “Black people are still underrepresented in research while being overrepresented in cancer mortality. So, Black in Cancer is about addressing both of these challenges. We want to bring Black researchers to the fore, and at the same time create a trusted, and culturally informed source of information for people who are dealing with a diagnosis of cancer.” Since its launch in 2020, Black in Cancer – which recently moved its headquarters to Cancer Research UK Cambridge Institute – has established partnerships with universities and research organisations in the UK and the US, created a conference series, developed a mentorship programme, and helped Black researchers access around £1.5m of funding. The organisation has also worked with Cancer Research UK (CRUK) on the launch of the Black Leaders in Cancer PhD Scholarship Programme, in partnership with Cambridge University, to help develop the next generation of Black scientists in cancer research and tackle barriers to progression. Find out more about the programme: https://lnkd.in/e7v_gEV9 #ChangingTheStoryOfCancer #CambridgeUniversity #CambridgeResearch

Although cancer remains one of the biggest causes of death across the world, we have made some great strides in cancer care over the last 50 years, particularly here in the UK. According to Cancer Research UK: ‘survival for all cancers combined in the UK has doubled since the early 1970’s.’ This shows that as technology has advanced in such a dramatic way over the last 50 years so has cancer care, and at Astronomical AI this is something we are actively looking to combine- Technological advances and cancer care, to revolutionise the next 50 years of cancer diagnosis and treatment, so we as a society can be better equipped to bring the fight back against cancer. ‘a new analysis commissioned by Cancer Research UK* shows that the progress we’re making has slowed down in the last 10 years compared to previous decades.’ This shows the need for new and innovative ways to ensure cancer is better diagnosed and treated, and using new methods, such as groundbreaking AI and neural networks, has been at the core of Astronomical AI’s values. Cancer research UK emphasises: ‘Governments must make concerted efforts to ensure more people are diagnosed at earlier stages when they are more likely to survive their cancer.’ This is something Astronomical AI is pushing for with its innovative lung cancer detection tool, we have always believed that a better way to screen early will result in better than treatment and our prototype uses the latest technology to catch cancer early. Post written has been based on this article: https://lnkd.in/d49eirgw Picture taken from: https://lnkd.in/e-DtZsyR - Research conducted by Adam, posted by Zane #astronomicalai #ai #cancerresearch #research #cancer #lungcancer

University of Southampton secures £1.4m to train future cancer scientists 🤝❤️🩹 The University of Southampton has been given a massive cash injection to train more doctors as clinical scientists dedicated to the fight against cancer. Nearly £1.4 million of funding is being provided by Cancer Research UK (CRUK) to develop a new generation of experts working on life-saving treatments. Clinician scientists play an essential role in translating cancer research – bridging the gap between the work carried out in laboratories and trials involving patients. The money from Cancer Research UK will be used by academics from Southampton to provide PhD places and post-doctorate training. Professor Andrew Davies, a cancer doctor at the University of Southampton, said the grant will help nurture a future generation of researchers pioneering cancer treatments. He added... Continue reading... https://lnkd.in/eeR8-6JQ #finance #funding #investing #cancer #health #medical #innovation #treatment #science #research #cruk #cancerresearch #businessnews #businessintelligence

In honour of World Cancer Day, we're launching a new series celebrating 20 years of progress at the BCI 🎉 Join us over the coming months as we reflect on our achievements and explore our hopes for driving further progress for people with cancer. The BCI was formed 20 years ago, emerging from Queen Mary Faculty of Medicine and Dentistry’s ambition to bring together some of the most eminent cancer research teams in London. Our purpose is to drive discoveries that positively impact the lives of people with or at risk of cancer. Highlights of our exciting progress over the past 20 years include: 1️⃣ Our researchers have led pivotal clinical trials bringing new therapies for bladder, breast, and mesothelioma cancers directly from our labs to the clinic, thanks to our close connections with leading hospitals including Barts Health NHS Trust. 2️⃣ We've developed innovative ways to detect cancer early when it is easier to treat. These include new methods to detect subtle clues of the disease in blood or urine. 3️⃣ Our research into the tumour microenvironment is helping to transform our understanding of cancer. We’ve shown it's not just about tumour cells – it's about the complex ecosystem around them that influences growth and response to therapy. 4️⃣ Harnessing the power of computational science, we're analysing complex cancer data from the clinic and the lab to tailor treatments and unravel the disease's evolution. Our hospital links, tissue banks and bioinformatics facility help us to study cancer from all angles. 5️⃣ Unveiling the biology driving cancer is the bedrock of our research. By revealing how cancer works, we’ve identified weaknesses that have led to new therapies. Today, we’re pursuing new horizons with exciting potential, such as RNA biology, epigenetics and metabolism. Thank you to our amazing community of scientists and professional services staff who continue to go the extra mile in support of life-changing research. 📰 Read more in our first article of the series: https://lnkd.in/ekUdSwDa #WorldCancerDay #CancerResearch #WCD2024 Queen Mary University of London Cancer Research UK Science and Innovation

It was 7 years ago in January, 2017 that The Princess Margaret Cancer Foundation announced the successful completion of the "Billion Dollar Challenge". This bold 5 year $1 Billion campaign was in support of the new world of Personalized Cancer Medicine. It was a starting point. The progress in Precision Cancer Medicine and the use of new tools in genomic medicine, AI, machine learning, and many others are helping revolutionize cancer research and patient care. Cancer is a disease of the genome and personalized, precise, effective and efficient treatment is becoming the standard of care. The need and the opportunity for a high level of collaboration among all researchers, clinicians, care givers and funders has never been more urgently needed. Canadians need and deserve this major collaborative effort. Precision Cancer Medicine needs to be a huge priority to drive improved outcomes. For all Canada. For all Canadians. Time for a massive commitment to collaboration, genomic medicine and precision cancer medicine. #cancerresearch #cancer #healthcare #precisionmedicine #genome #genomic #cancercare #philanthropy #canada #innovation #collaboration #medicine #research #artificialintelligence #fundraising #foundations

In 2018, the UCSF Helen Diller Family Comprehensive Cancer Center undertook a strategic planning process centered on what cancer research might look like in the year 2030. In the May 2024 #AACICommentary, UCSF leaders share how a robust strategic plan can help advance a cancer center's mission. https://lnkd.in/eR9BH7vz #StrategicPlanning

Happy Research Appreciation Day! 🎉 🔬 Today, we're celebrating the ground-breaking work of our exceptional childhood cancer researchers. Thanks to their dedication and innovation, we've seen incredible progress over the past few decades. Back in the 1960s, only three in ten children survived cancer. Today, over eight in ten children survive. We are thrilled to introduce Professor Suzanne Turner, one of our leading childhood cancer researchers! Suzanne leads seven research projects funded by CCLG and The Little Princess Trust, specialising in lymphoma—a type of childhood blood cancer. As a global expert, Suzanne works with researchers in Uganda to detect endemic Burkitt lymphoma faster, investigating how genetics are linked to anaplastic large cell lymphoma (ALCL). One of her projects was funded by the CCLG Special Named Fund Super Ru, set up for Ruari, who was diagnosed with ALCL in 2018. This research involved analysing cancer samples from across Europe to identify genetic changes in this cancer to see how they affected survival. She discovered two types of genetic errors common in anaplastic lymphoma kinase-negative ALCL. This breakthrough paves the way for developing targeted treatments for patients with this subtype. Find out more about Suzanne’s project at: https://bit.ly/4cqAJIo Let's continue to support and celebrate our researchers, who make a difference every single day for children and young people with cancer! Join us in saying thank you in the comments below 👇 Ashley | Samuel | Georgina | Tina | Ellie | Naomi | Claire | Amy | Phil | Sharon | Rob | Hannah | Lizzie | Juliet | Vicki | Jeanette #CCLG #ChildhoodCancer #ChildhoodCancerResearch #ResearchAppreciationDay

🎗️ Childhood Cancer Awareness: Advancing Leukemia Monitoring with AI 🧑⚕️📊 Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and early response to treatment is key to improving outcomes. In a significant breakthrough, researchers are using artificial intelligence and computer vision to monitor leukemia in children with greater accuracy and efficiency. This new method involves a deep learning model applied to bone marrow samples, achieving over 88% accuracy in identifying ALL cells—without the need for expensive fluorescent markers. By focusing on features from simple bright-field and dark-field cell images, this technique is not only fast and affordable, but it also opens the door to automated, point-of-care testing. 🔬 Key Innovations: - Label-free monitoring—no complex dyes or labels required. - Provides a cost-effective solution for leukemia monitoring. - Holds potential to be adapted for other types of leukemia, revolutionizing how residual disease is tracked. This AI-driven innovation could play a pivotal role in improving childhood cancer care, making advanced diagnostics more accessible and saving more young lives. 💛 Read More: https://lnkd.in/dHtZ_was #ChildhoodCancerAwareness #AIinHealthcare #LeukemiaResearch #ChildhoodLeukemia #PrecisionMedicine #CancerCareInnovation #HealthcareForChildren #AIforGood #SaveTheChildren Prinses Máxima Centrum voor kinderoncologie St. Jude Children's Research Hospital Children's Cancer Institute Children's Oncology Group Children's Cancer Center The Institute of Cancer Research National Cancer Institute (NCI) Cincinnati Children's Children's Brain Tumor Foundation American Cancer Society Indian Cancer Society

Applications for Our Second Eve Fellowship are open! We are pleased to announce our second Fellowship funding call, continuing our partnership with North West Cancer Research. This Fellowship is dedicated to advancing ovarian cancer research, focused on early detection, prevention, screening, and understanding inherited risk.    Our Fellowship programme forms an essential part of our research efforts. In order to realise a future where gynae cancers are diseases of the past, we need to invest in the next generation of researchers and support them in becoming leaders in the field. This programme has the potential to create new great breakthroughs in early detection, prevention and screening for the gynae cancers. Ovarian cancer is the sixth most common cancer in women in the UK, with over 7,500 people diagnosed every year. It is most common in post-menopausal women, although it can affect anyone with ovaries at any age. 10% of ovarian cancers are related to an inherited risk, like a BRCA alteration. Research into the early detection, prevention and screening of ovarian cancer is underfunded. Our CEO, Athena Lamnisos says ‘Breakthroughs in this area have the potential to make a huge difference in saving lives and can help to drive the change we need to prevent or earlier diagnose gynae cancers’. The ovarian fellowship scheme is now open to early and mid-career researchers at any UK institution, with a proven track record in gynaecological cancer research. For more information and to apply click here: https://lnkd.in/edpyvZpr #OvarianCancer #CancerResearch #Research #OpenCall #Fellowship #TheEveAppeal #EveAppeal #EveResearch

Delighted to be an invited speaker at the React4Kids congress “Childhood Cancers: Understand to Treat”, which kicks off today, September 30th, 2024, in Pornichet, France. The congress gathers French and international speakers in the area of basic and translational research in pediatric oncology. In my talk, I will focus on our recent exciting discoveries using epigenome-wide analysis to trace pediatric leukemia back to birth. These findings provide proof-of-concept for detecting at birth epigenetic alterations that predispose to cancer development and influence the disease's progression and outcome in patients. A big thank you to the organizers, Cindy Gallerne, PhD, Benjamin Benjamin ORY, and François Lamoureux, for this incredible opportunity. I’m looking forward to meeting leading scientists in pediatric cancer research and exploring future collaborations in this exciting field. I would also like to take this opportunity to express my heartfelt gratitude to the entire team from the Epigenomics and Mechanisms Branch at IARC - International Agency for Research on Cancer / World Health Organization, and our international collaborators (too many to name) whose dedication and hard work have been instrumental in achieving the results presented in my lecture. Together, we are making strides toward a better understanding of cancer in children. This congress is timely, as it nicely concludes Childhood Cancer Awareness Month 2024. You can find more on our research on our Project Websites https://lnkd.in/dkp9Zbbn and IARC https://lnkd.in/dECMvGJk https://lnkd.in/dMT4yMMu P.S. The image below is my creative attempt to visually capture the theme of my talk and this conference with the help of AI. #PediatricCancer #ChildhoodCancerResearch #Epigenomics #CancerPrevention #CollaborativeScience #IARC #WHO #ResearchCommunity #ChildhoodCancerAwareness #Environment #CancerCauses